The Persistence of Nystatin Use for Dermatophyte Infections.
J Drugs Dermatol
; 22(12): e49-e50, 2023 12 01.
Article
em En
| MEDLINE
| ID: mdl-38051827
ABSTRACT
BACKGROUND:
Despite the limited use of nystatin for tinea infections, physicians may continue to use it.METHODS:
We assessed the National Ambulatory Medical Care Survey for all to determine the extent of topical nystatin use in tinea infections.RESULTS:
Topical nystatin was used at 4.3% (2.1%, 6.0%) of all tinea infection visits. It was not used at visits with dermatologists and was most common among family medicine physicians (P=.02).DISCUSSION:
Physicians are continuing to use nystatin for the treatment of tinea infections. Dermatologists have discontinued this treatment regimen, whereas other specialties have an opportunity to further improve their knowledge in this regard. J Drugs Dermatol. 2023;22(12)e49-e50. doi10.36849/JDD.5606e.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Tinha
/
Arthrodermataceae
Limite:
Humans
Idioma:
En
Revista:
J Drugs Dermatol
Assunto da revista:
DERMATOLOGIA
Ano de publicação:
2023
Tipo de documento:
Article